|
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 19.53 USD | -4.17% |
|
0.00% | - |
| 06/08 | Attovia Therapeutics, Inc.(NasdaqGM:ATTO) added to NASDAQ Composite Index | CI |
| 04/08 | Attovia Therapeutics, Inc. has completed an IPO in the amount of $289 million. | CI |
| 1 day | -4.17% |
| 1 week | 19.63 |  | 22.79 |
| 1 month | 19.63 | | 22.79 |
| Current year | 19.63 | | 22.79 |
| 1 year | 19.63 | | 22.79 |
| 3 years | 19.63 | | 22.79 |
| 5 years | 19.63 | | 22.79 |
| 10 years | 19.63 | | 22.79 |
| Manager | Title | Age | Since |
|---|---|---|---|
Petter Veiby
CTO | Chief Tech/Sci/R&D Officer | 61 | 01/06/2023 |
Tao Fu
CEO | Chief Executive Officer | 54 | 01/04/2023 |
Zaneta Odrowaz
SEC | Corporate Secretary | 42 | 01/04/2023 |
| Director | Title | Age | Since |
|---|---|---|---|
Aaron Royston
BRD | Director/Board Member | 42 | 01/06/2023 |
Tao Fu
BRD | Director/Board Member | 54 | 01/04/2023 |
James Topper
CHM | Chairman | 64 | 01/06/2023 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 4/8/26 | VV Manager LLC
| Other | Company | 939,425 | 2.1832% | |
| 4/8/26 | Redmile Group LLC
| Other | Company | 782,854 | 1.8194% | |
| 4/8/26 | venBio Partners LLC
| Other | Company | 3,799,015 | 8.8290% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -4.17% | 0.00% | - | - | 877M | |
| -3.25% | +13.72% | +52.49% | +88.86% | 62.92B | |
| +1.72% | +3.06% | +33.34% | +73.67% | 54.32B | |
| +1.42% | +1.14% | -17.73% | -6.99% | 22.91B | |
| -1.99% | +32.01% | +19.09% | +495.15% | 28.73B | |
| +10.83% | +18.38% | +52.76% | +4.58% | 21.65B | |
| +8.31% | +9.07% | +40.13% | -20.23% | 17.76B | |
| -3.37% | +25.85% | +213.21% | +369.13% | 16.47B | |
| +6.20% | +11.51% | +34.94% | +681.88% | 15.48B | |
| +1.71% | -0.50% | +41.12% | +160.56% | 13.12B | |
| Average | +1.86% | +7.27% | +52.15% | +205.18% | 25.42B | |
| Weighted average by Cap. | +1.32% | +8.58% | +46.19% | +166.32% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | - | 1.35 1.17 1.1 1 1.89 128.6 1.92 12.83 5.04 64.25 5.07 4.96 213.86 |
| Net income | -39.8M -34.54M -32.34M -29.58M -55.85M -3.79B -56.58M -378M -148M -1.89B -149M -146M -6.31B | -60.63M -52.61M -49.26M -45.07M -85.08M -5.78B -86.19M -576M -226M -2.89B -228M -223M -9.6B |
| Net Debt | - | - |
Employees
44
| Date | Price | Change | Volume |
|---|---|---|---|
| 07/08/26 | USD 19.75 | -3.09% | 9,878 |
| 06/08/26 | USD 20.38 | -6.94% | 413,248 |
- Stock Market
- Stocks
- ATTO Stock
Select your edition
All financial news and data tailored to specific country editions
